Baroness Meacher
Main Page: Baroness Meacher (Crossbench - Life peer)
To ask Her Majesty’s Government what plans they have to contribute to the work of the European Union to prepare for the United Nations General Assembly Special Session on Drug Policy in 2016.
My Lords, the Government are committed to taking a leadership role in preparing for the United Nations General Assembly Special Session on Drugs, including through our representations in the European Union. Of course, we must work with our international partners to share our expertise and indeed to promote a balanced and evidence-based approach to drugs that is within international drug control conventions.
I thank the Minister for his reply. On 26 June 2013, the UN Secretary-General, Ban Ki-moon, appealed to all member states to consider “all options” in drug policy in the lead-up to the 2016 UN special session. Yesterday the former UK ambassador to Afghanistan claimed that to put doctors and pharmacists in control of heroin supply in the UK—with tough regulation—will save lives, improve health and reduce crime. Will the Minister assure the House that the Government will extend their review of drug policy to include a rigorous, independent study of the costs and benefits of a regulatory regime as proposed by our former ambassador—and if not, why not?
First, I pay tribute to the work the noble Baroness has done in this field. She has brought to the fore on many occasions the importance of reviewing drugs policy. The Government have taken a broad view of this. If we look at the statistics, it is commendable that drug usage domestically is down and we have seen a greater emphasis being put on helping people overcome drugs issues. Nevertheless, she may well be aware that there is an international comparators report due within the next two to three months, and we will be reviewing what we find in terms of best practice across a range of countries, not just within the EU.